Certified Advisory Corp’s AbbVie ABBV Stock Holding History

Certified Advisory Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	7,683 +44	+0.6%	+$9.47K	0.16%	126
2026 Q1	$1.66M	Sell	7,639 -18	-0.2%	-$3.99K	0.15%	131
2025 Q4	$1.75M	Buy	7,657 +11	+0.1%	+$2.51K	0.16%	129
2025 Q3	$1.77M	Sell	7,646 -207	-3%	-$42.2K	0.17%	122
2025 Q2	$1.46M	Buy	7,853 +344	+5%	+$63.9K	0.15%	128
2025 Q1	$1.57M	Buy	7,509 +4	+0.1%	+$778	0.18%	118
2024 Q4	$1.33M	Buy	7,505 +69	+0.9%	+$12.7K	0.14%	126
2024 Q3	$1.47M	Sell	7,436 -68	-0.9%	-$12.7K	0.16%	122
2024 Q2	$1.29M	Sell	7,504 -398	-5%	-$65.9K	0.16%	120
2024 Q1	$1.44M	Buy	7,902 +545	+7%	+$93.9K	0.2%	110
2023 Q4	$1.14M	Buy	7,357 +24	+0.3%	+$3.5K	0.17%	121
2023 Q3	$1.09M	Sell	7,333 -8	-0.1%	-$1.17K	0.2%	107
2023 Q2	$989K	Buy	7,341 +518	+8%	+$76K	0.18%	110
2023 Q1	$1.09M	Buy	6,823 +408	+6%	+$62.4K	0.19%	114
2022 Q4	$1.04M	Sell	6,415 -195	-3%	-$29.9K	0.2%	114
2022 Q3	$887K	Buy	6,610 +44	+0.7%	+$6.31K	0.2%	114
2022 Q2	$1M	Buy	6,566 +64	+1%	+$9.78K	0.22%	105
2022 Q1	$1.05M	Buy	6,502 +30	+0.5%	+$4.36K	0.22%	107
2021 Q4	$876K	Buy	6,472 +34	+0.5%	+$4.02K	0.19%	123
2021 Q3	$694K	Sell	6,438 -1	-0%	-$114	0.17%	128
2021 Q2	$725K	Sell	6,439 -48	-0.7%	-$5.41K	0.18%	125
2021 Q1	$702K	Buy	+6,487	New	+$694K	0.18%	114
2020 Q2	$639K	Buy	6,506 +1,592	+32%	+$140K	0.21%	109
2020 Q1	$375K	Buy	4,914 +105	+2%	+$8.94K	0.15%	123
2019 Q4	$426K	Sell	4,809 -870	-15%	-$72.2K	0.14%	132
2019 Q3	$430K	Sell	5,679 -335	-6%	-$23K	0.15%	124
2019 Q2	$438K	Buy	6,014 +129	+2%	+$10.1K	0.16%	112
2019 Q1	$475K	Buy	5,885 +527	+10%	+$43.1K	0.2%	101
2018 Q4	$494K	Buy	5,358 +294	+6%	+$25.9K	0.26%	86
2018 Q3	$479K	Sell	5,064 -53	-1%	-$5.03K	0.22%	94
2018 Q2	$474K	Buy	5,117 +120	+2%	+$11.7K	0.26%	88
2018 Q1	$472K	Buy	4,997 +414	+9%	+$45.5K	0.28%	88
2017 Q4	$442K	Buy	+4,583	New	+$432K	0.32%	69

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Certified Advisory Corp's ABBV Position: Q2 2026 in Review

Certified Advisory Corp increased its AbbVie (ABBV) stake by 0.58% in Q2 2026, buying an estimated $9.47K and bringing the position to 7,683 shares worth $1.93M. The position accounts for 0.16% of the portfolio, ranked #126.

Certified Advisory Corp first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Certified Advisory Corp held 7,683 shares of AbbVie worth $1.93M as of Q2 2026.
Certified Advisory Corp bought 44 AbbVie shares in Q2 2026, an estimated $9.47K.
AbbVie made up 0.16% of Certified Advisory Corp's portfolio in Q2 2026, its #126 holding.
Certified Advisory Corp first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Certified Advisory Corp's 13F filing for Q2 2026, filed 16 Jul 2026.